Sotera Health Q1 revenue up 12.5% to $248M; net income $6M; reaffirms 2024 outlook

Sotera Health Co

2024-Q1 EPS reported $0.02 revenue$248,176,000

Q1 net revenues $248M (+12.5% YoY); net income $6M ($0.02 diluted EPS) vs $3M ($0.01) in Q1 2023.
Adjusted EBITDA $112M (+13.7% YoY); Adjusted EPS $0.13 flat YoY.
Sterigenics segment net revenues $166M (+4.1%), segment income $86M (+3.6%).
Co reaffirms 2024 outlook; cites EPA finalizing updated NESHAP for ethylene oxide as manageable.
8-K/A filed to correct typo in prior exhibit; no impact on reported income metrics.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sotera Health Co reported the three months ended March 31, 2024 results: revenue $248 million, net income $6 million, EPS $0.02 per diluted share. Guidance reaffirmed.

Period: the three months ended March 31, 2024
Revenue: $248 million
Net income: $6 million
EPS: $0.02 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

First-quarter 2024 net revenues increased 12.5% to $248 million, compared to $221 million in the first-quarter 2023.

View on SEC.gov

222 earnings releases filed in the last 30 days. Browse all earnings releases →

Sotera Health Co filing history →

Source: SEC EDGAR

accession 0001822479-24-000017

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.